Latest Lead News

Coolabah Metals Limited is set to transform into a producing miner with its $15-20 million capital raise, conditional on acquiring Broken Hill Mines Pty Ltd and resuming ASX trading.

Lumos Diagnostics has secured Medicare reimbursement for its FebriDx test from a sixth Medicare Administrative Contractor, covering over 85% of US Medicare payment regions. This milestone advances the company’s commercialisation efforts in the US healthcare market.

PainChek Limited has secured a pivotal reseller and integration deal with Eldermark Software, positioning its AI-driven pain assessment app for a major US market rollout pending FDA approval.

Propel Funeral Partners has released its FY25 financial guidance projecting steady revenue growth despite temporary industry volume contraction, alongside announcing the upcoming retirement of its Managing Director and Co-Founder.

OpenLearning has secured a significant five-year SaaS contract with National University, one of the Philippines’ largest private universities, marking a major step in its regional expansion and AI-driven LMS adoption.

Silver Mines Limited has received a key determination from the NSW Planning Secretary confirming the transmission line as part of the Bowdens Silver Project development, paving the way for progress towards final consent.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

Lincoln Minerals has confirmed historical high-grade copper, lead, zinc, and silver assays at its Minbrie project through re-assaying legacy drill core, reinforcing the prospect's district-scale potential in South Australia’s Gawler Craton.

Telstra Group Limited has unveiled its Connected Future 30 Strategy, setting a long-term roadmap for the telecommunications giant's evolution over the next three decades.

Syrah Resources has clarified its offtake agreement with Tesla, extending the final qualification deadline for its Vidalia anode active material facility to February 2027. Both companies continue advancing towards commercial sales despite the extended timeline.

Orbital Corporation has appointed Stephen Pearce as CEO, marking a strategic shift from engine development to commercialising propulsion and flight management systems for defence UAVs.

Recce Pharmaceuticals has secured a significant patent acceptance in China for its RECCE® anti-infectives, broadening its intellectual property footprint in the world’s second-largest pharmaceutical market.